Researchers at Mount Sinai have utilized wearable devices such as smartwatches and fitness trackers in a longitudinal study to objectively measure sleep patterns in patients with inflammatory bowel disease (IBD). Published in Clinical Gastroenterology and Hepatology, the study shows that inflammatory processes intrinsic to IBD significantly affect sleep metrics independently of clinical symptoms. Over 100 participants’ sleep stages and transitions were tracked alongside inflammatory markers, providing novel insights into the disease’s impact on sleep quality and potential avenues for management.